Fuente RSS de PHARMA JAPAN - REGULATORY -

Quienes siguen a PHARMA JAPAN - REGULATORY - también siguen

• EC Decisions concerning orphan medicinal products ec.europa.eu
• FiercePharma: Manufacturing fiercepharma.com
• FiercePharma: Marketing fiercepharma.com
• EC procedures on the change of status of human medicinal products ec.europa.eu
• G-BA: Letzte Änderungen der Website g-ba.de
• Ozempic (semaglutide) - Novo Nordisk A/S ec.europa.eu
• HAS - Bulletin officiel has-sante.fr
• Medicines and Healthcare products Regulatory Agency - Activity on GOV.UK gov.uk

Más feeds RSS de pj.jiho.jp

• PHARMA JAPAN - Latest - https://pj.jiho.jp/article/rss.xml
• PHARMA JAPAN - BUSINESS - https://pj.jiho.jp/genre/2/rss.xml
• PHARMA JAPAN - ORGANIZATION - https://pj.jiho.jp/genre/9/rss.xml
• PHARMA JAPAN - ACADEMIA - https://pj.jiho.jp/genre/10/rss.xml
• REGULATORY | PHARMA JAPAN | GU https://rss.app/feeds/Z3Q6MgiOcCi7Y1y8.xml

Ver todos los feeds RSS de pj.jiho.jp

Ver todos los feeds RSS de Salud

Más canales RSS para explorar

• ClinicalTrials.gov: Rozanolixizumab (UCB7665) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: Zilucoplan (RA101495) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days clinicaltrials.gov
• ClinicalTrials.gov: LNP023 | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days clinicaltrials.gov